DE69434239D1 - Verwendung von Progesteronrezeptor Antagonisten zur Verhütung oder Behinderung der Fertilisation - Google Patents

Verwendung von Progesteronrezeptor Antagonisten zur Verhütung oder Behinderung der Fertilisation

Info

Publication number
DE69434239D1
DE69434239D1 DE69434239T DE69434239T DE69434239D1 DE 69434239 D1 DE69434239 D1 DE 69434239D1 DE 69434239 T DE69434239 T DE 69434239T DE 69434239 T DE69434239 T DE 69434239T DE 69434239 D1 DE69434239 D1 DE 69434239D1
Authority
DE
Germany
Prior art keywords
progesterone receptor
fertilization
obstruction
prevention
receptor antagonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69434239T
Other languages
English (en)
Other versions
DE69434239T2 (de
Inventor
Garry D Hodgen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eastern Virginia Medical School
Original Assignee
Eastern Virginia Medical School
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eastern Virginia Medical School filed Critical Eastern Virginia Medical School
Publication of DE69434239D1 publication Critical patent/DE69434239D1/de
Application granted granted Critical
Publication of DE69434239T2 publication Critical patent/DE69434239T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Catching Or Destruction (AREA)
  • Pens And Brushes (AREA)
  • Fertilizers (AREA)
  • Fats And Perfumes (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DE69434239T 1993-02-19 1994-02-18 Verwendung eines Progesteronrezeptor-Antagonisten zur Verhütung oder Hemmung der Befruchtung Expired - Lifetime DE69434239T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19791 1993-02-19
US08/019,791 US5516769A (en) 1993-02-19 1993-02-19 Method of inhibiting fertilization

Publications (2)

Publication Number Publication Date
DE69434239D1 true DE69434239D1 (de) 2005-02-17
DE69434239T2 DE69434239T2 (de) 2006-03-30

Family

ID=21795040

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69430732T Expired - Lifetime DE69430732T2 (de) 1993-02-19 1994-02-18 Kit zur verhütung oder hemmung der befruchtung
DE69434239T Expired - Lifetime DE69434239T2 (de) 1993-02-19 1994-02-18 Verwendung eines Progesteronrezeptor-Antagonisten zur Verhütung oder Hemmung der Befruchtung

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69430732T Expired - Lifetime DE69430732T2 (de) 1993-02-19 1994-02-18 Kit zur verhütung oder hemmung der befruchtung

Country Status (24)

Country Link
US (1) US5516769A (de)
EP (2) EP1159965B1 (de)
JP (1) JP3054780B2 (de)
KR (1) KR100232833B1 (de)
AT (2) ATE286734T1 (de)
AU (1) AU692150B2 (de)
BG (1) BG62431B1 (de)
BR (1) BR9406666A (de)
CA (1) CA2156493C (de)
CZ (1) CZ294325B6 (de)
DE (2) DE69430732T2 (de)
DK (2) DK1159965T3 (de)
ES (1) ES2231356T3 (de)
FI (1) FI114687B (de)
HU (1) HU221162B1 (de)
NO (1) NO307916B1 (de)
NZ (1) NZ262998A (de)
PL (1) PL175440B1 (de)
PT (2) PT684825E (de)
RO (1) RO118565B1 (de)
RU (1) RU2139055C1 (de)
SK (1) SK282068B6 (de)
UA (1) UA41351C2 (de)
WO (1) WO1994018982A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9301121A (es) 1992-03-02 1993-09-01 Schering Ag Metodo y equipo para la contracepcion oral y regulacion de la menstruacion con estrogeno/progestina/aniprogestina.
US7704983B1 (en) 1992-03-02 2010-04-27 Eastern Virginia Medical School Antiprogestin method for reducing side effects associated with low dosage HRT and oral contraception
US5439913A (en) 1992-05-12 1995-08-08 Schering Aktiengesellschaft Contraception method using competitive progesterone antagonists and novel compounds useful therein
DE4344463A1 (de) * 1993-12-22 1995-06-29 Schering Ag Kombinationsprodukt zur Kontrazeption
AU781835B2 (en) 1999-08-31 2005-06-16 Schering Aktiengesellschaft Mesoprogestins (progesterone receptor modulators) as a component of female contraceptives

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3890356A (en) * 1973-03-26 1975-06-17 Richardson Merrell Inc 7-Alkyl-{66 {hu 3,5{b -steroids
US4000273A (en) * 1973-11-01 1976-12-28 Richardson-Merrell Inc. Method for the control of fertility
US3928398A (en) * 1973-11-01 1975-12-23 Richardson Merrell Inc Derivatives of 7{60 -methylestr-4-en-3{60 ,17{62 -diol
US4416822A (en) * 1982-07-09 1983-11-22 The Upjohn Company 17β-Difluoromethyl steroids
IL68222A (en) * 1983-03-24 1987-02-27 Yeda Res & Dev Contraceptive compositions comprising a progesterone antagonist and a blocker of progesterone activity
AU572589B2 (en) * 1983-12-14 1988-05-12 Upjohn Company, The 11(alpha)-difluoromethyl and (e)-and (z)-11-fluoromethylene steroids
IE71203B1 (en) * 1990-12-13 1997-02-12 Akzo Nv Low estrogen oral contraceptives

Also Published As

Publication number Publication date
BG62431B1 (bg) 1999-11-30
PL310357A1 (en) 1995-12-11
EP1159965A3 (de) 2002-05-22
JPH08510992A (ja) 1996-11-19
US5516769A (en) 1996-05-14
KR960700726A (ko) 1996-02-24
RU2139055C1 (ru) 1999-10-10
NO307916B1 (no) 2000-06-19
PL175440B1 (pl) 1998-12-31
CZ205095A3 (en) 1996-01-17
PT1159965E (pt) 2005-03-31
NZ262998A (en) 1997-06-24
EP0684825B1 (de) 2002-06-05
NO953242L (no) 1995-08-17
CA2156493C (en) 2002-10-29
PT684825E (pt) 2002-10-31
WO1994018982A1 (en) 1994-09-01
AU6299294A (en) 1994-09-14
AU692150B2 (en) 1998-06-04
EP1159965A2 (de) 2001-12-05
FI953878A0 (fi) 1995-08-17
HUT72079A (en) 1996-03-28
EP0684825A1 (de) 1995-12-06
JP3054780B2 (ja) 2000-06-19
BG99867A (bg) 1996-04-30
DE69434239T2 (de) 2006-03-30
DK1159965T3 (da) 2005-05-23
ATE218347T1 (de) 2002-06-15
KR100232833B1 (ko) 1999-12-01
UA41351C2 (uk) 2001-09-17
RO118565B1 (ro) 2003-07-30
DK0684825T3 (da) 2002-07-15
NO953242D0 (no) 1995-08-17
CA2156493A1 (en) 1994-09-01
SK282068B6 (sk) 2001-10-08
FI953878A (fi) 1995-08-17
HU221162B1 (en) 2002-08-28
DE69430732D1 (de) 2002-07-11
FI114687B (fi) 2004-12-15
EP1159965B1 (de) 2005-01-12
ATE286734T1 (de) 2005-01-15
DE69430732T2 (de) 2002-10-24
CZ294325B6 (cs) 2004-11-10
BR9406666A (pt) 1996-01-23
ES2231356T3 (es) 2005-05-16
EP0684825A4 (de) 1998-01-14
SK101395A3 (en) 1997-04-09

Similar Documents

Publication Publication Date Title
NO2018017I1 (no) Interleukin-6 (IL-6) reseptor antistoff (Krav 1 i NO321089). Forlenget SPC
CL2003002756A1 (es) Compuestos derivados de (1-carbamoil-1,1-defenilmetil)-1-[substituido)alquil]purrolidinas; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento del sindrome de intestino irritable o incontinencia.
IT8122675A0 (it) Mercaptoacil derivati di varie proline 4 sostituite e relative composizioni utili per il trattamento dell'ipertensione.
IL107884A0 (en) Sulphonamides, their manufacture and pharmaceutical compositions containing them
ATE236115T1 (de) Dimer-selektive rxr modulatoren und verfahren zu ihrer verwendung
ES2114605T5 (es) Metodo anticonceptivo que emplea un antagonista de progesterona competitivo y nuevos compuestos utilizados en el.
DE69713582D1 (de) Zimtsäurederivate und deren verwendung als integrin-antagonisten
ATE354364T1 (de) Verwendung von at-1 rezeptorantagonisten oder at- 2 rezeptormodulatoren zur behandlung von erkrankungen, die mit einer erhöhung an at-1 oder at-2 rezeptoren verbunden sind
ES2184858T3 (es) Cetoenoles alquil-dihalogenofenil substituidos como pesticidas y herbicidas.
IL94915A0 (en) Substituted quinazolinones and pharmaceutical compositions containing them
ES2118820T3 (es) Anticuerpos monoclonales para receptores de factores de celulas pluripotentes.
FI960727A (fi) Neurokiniiniantagonisteina käyttökelpoiset heterosyklit
DE69425655D1 (de) Antagonisten des fibrinogenrezeptors
DE69904922D1 (de) Pharmazeutische zusammensetzung zur behandlung von alkoholabhängigkeit, die opioid antagonisten mit nmda-rezeptorkomplex-modulatoren enthält
WO2001023521A3 (en) Polypeptide derivatives of parathyroid hormone (PTH)
DE69434239D1 (de) Verwendung von Progesteronrezeptor Antagonisten zur Verhütung oder Behinderung der Fertilisation
ATE165614T1 (de) Zusammensetzung für entwässerndes bituminöses mischgut
ATE258438T1 (de) Verwendung von antagonisten des 5-htia rezeptors zur behandlung von harninkontinenz
DK0558139T3 (da) Fremgangsmåde til fremstilling af fibrinogenreceptorantagonister
EP0714295A4 (de)
ATE412670T1 (de) Parathyroid hormon (pth) polypeptidderivate
EP0467365A3 (en) Use of a 5-hydroxytryptamine-3(5-ht3) receptor antagonist for the preparation of a pharmaceutical composition for treating urinary incontinence
IS3929A (is) Hliðstæð aðferð við framleiðslu 3-(N-ísóprópýl-N-n-própýlamínó) -5-(N-ísóprópýl)-karbamoylkróman
DK0379308T3 (da) Fremgangsmåde til selektivt at blokere 5HT2 receptorer
KR900013069A (ko) 인체 태반성 홀몬(Human Chorionic Gonadotropin)의 미량 측정용 단일클론항체(monoclonal antibody) 분비 세포주

Legal Events

Date Code Title Description
8364 No opposition during term of opposition